$TELA News

TELA Bio (TELA) Stock Sees Fair Value Cut As Analysts Weigh New Leadership Risks

TELA Bio, Inc. (TELA) Shareholder/Analyst Call Transcript

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

Craig-Hallum Initiates Coverage On TELA Bio with Buy Rating, Announces Price Target of $2

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

TELA Bio Announces $17M Annual Expense Reduction Through 20% Workforce Streamlining and Resource Optimization, Extending Cash Runway Into 2028

TELA Bio COO And CFO Roberto Cuca To Step Down Effective Immediately

TELA Bio (TELA) Q2 2026 Earnings Call Transcript

TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...

TELA Bio, Inc. Q2 2026 Earnings Call Summary

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Reports Second Quarter 2026 Financial Results

TELA Bio Q2 EPS $(0.20) Misses $(0.18) Estimate, Sales $19.291M Miss $20.008M Estimate

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Appoints Heather Getz CEO, Effective Immediately

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

TELA Bio to Announce Second Quarter 2026 Financial Results

Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25

TELA Bio, Inc. Q1 2026 Earnings Call Summary